RankAlpha logo
Back to Rankings

QURE

uniQureF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
QURE vs peer average
31/100
QURE vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · C 2 · D 1 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

CAPR is the first available peer comparator.

Capricor is the closest packet peer for small-cap clinical/regulatory biotech risk, though modality and disease focus differ; it is more useful as a catalyst-volatility benchmark than a direct valuation read-through peer.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCAPRCapricor Therapeutics
QURE
uniQure
CAPR
Capricor Therapeutics
Grade
F
F
Momentum
82
15
Value
41
41
Sentiment
22
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs CAPR

QURE / CAPR
Grade Position
Below peers
QURE vs. peer average (F vs. D)
31/100
Momentum
82
QURE
Value
41
QURE
Sentiment
22
QURE

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs QURE
1
CAPR
CAPR
F
20/100
Even
2
AGIO
AGIO
F
20/100
Even
3
CLDX
Celldex Therapeutics Inc Common
D
40/100
-1
4
MBX
MBX Biosciences Inc Common
F
20/100
Even
5
VCYT
Veracyte Inc Common
C
60/100
-2
CAPR is the first peer returned for this comparison set.